Association of phosphatidylcholine and NSAIDs as a novel strategy to reduce gastrointestinal toxicity.
about
Current perspectives in NSAID-induced gastropathyPiroxicam-β-cyclodextrin: a GI safer piroxicamIn vitro evidence that phosphatidylcholine protects against indomethacin/bile acid-induced injury to cells.Enhanced inhibitory synaptic transmission in the spinal dorsal horn mediates antinociceptive effects of TC-2559.Mitigation of indomethacin-induced gastrointestinal damages in fat-1 transgenic mice via gate-keeper action of ω-3-polyunsaturated fatty acids.NSAID gastropathy and enteropathy: distinct pathogenesis likely necessitates distinct prevention strategiesIbuprofen: from invention to an OTC therapeutic mainstay.Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.Recent Advances in NSAIDs-Induced Enteropathy Therapeutics: New Options, New Challenges.Nonsteroidal Anti-Inflammatory Therapy: A Journey Toward Safety.Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.Investigational drugs targeting the prostaglandin E2 signaling pathway for the treatment of inflammatory pain.Insight into NSAID-induced membrane alterations, pathogenesis and therapeutics: characterization of interaction of NSAIDs with phosphatidylcholine.Indomethacin injury to the rat small intestine is dependent upon biliary secretion and is associated with overgrowth of enterococci.Aggregation behavior of ibuprofen, cholic acid and dodecylphosphocholine micelles.Non-steroidal anti-inflammatory drug-induced enteropathy.Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety.The role of food for the formation and prevention of gastrointestinal lesions induced by aspirin in cats.Orally administered phosphatidic acids and lysophosphatidic acids ameliorate aspirin-induced stomach mucosal injury in mice.Non-steroidal anti-inflammatory drug-induced enteropathy.Unlocking Aspirin's Chemopreventive Activity: Role of Irreversibly Inhibiting Platelet Cyclooxygenase-1.Chemoprevention with phosphatidylcholine non-steroidal anti-inflammatory drugs in vivo and in vitro.
P2860
Q26827673-2EBAB05E-1F52-4873-BEB9-CD74EFFF5103Q27023475-373C61D4-A7FE-4CF9-9C85-09D556E942C8Q35035226-9982A869-355F-4273-8343-A1F0D4E36D32Q35181505-4427DA3D-7B2D-4445-9856-D8D8C9AC229EQ37278027-824F4878-FEC8-4707-A836-225826E93BFBQ37882741-3D133BF3-CE2A-440D-B098-32CBD72ABBE5Q38060825-27A6139D-56B4-4BB4-A09D-A99450DF28A5Q38097424-C75878E2-43B0-4B97-AE1D-B1AFFEEBFF15Q38155495-39E9097A-1368-417B-B010-AAAA7DEEB0D7Q38558587-83986A2A-93A6-4300-BF3B-7DBD6B8DF9F6Q38745843-A91813CB-2C0C-446A-A779-9F7BD8109664Q39007494-03F341BC-FFE5-4D2F-854F-65E7B7555788Q39361317-CD627BB6-E1CD-46C4-A3DC-F4043FCE0D78Q39710654-7F1B5828-7071-4F59-86FA-C7454FE32FB7Q42097264-72A6AFB8-3A64-4185-AED2-ED8DEFDE9B51Q42244383-78E4E5E2-5685-41AC-8A70-DB66D060FF5EQ43247710-43787A4F-D6C0-48D2-AF8A-C4B343F958E4Q43561464-4F23A503-B018-44E8-8224-3E13345B32EBQ44232180-CDCEFEAF-FF71-436D-93E9-2B29D6169A0EQ45400230-9A022A21-2046-4594-96C3-0858720B19D2Q48009155-E5E2DCAC-BC7C-4A68-941F-EE980D8C2637Q55176341-5A7D5C8D-6EA6-4476-96B6-DAE6D9893A72
P2860
Association of phosphatidylcholine and NSAIDs as a novel strategy to reduce gastrointestinal toxicity.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@en
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@nl
type
label
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@en
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@nl
prefLabel
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@en
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@nl
P2093
P1433
P1476
Association of phosphatidylcho ...... uce gastrointestinal toxicity.
@en
P2093
Lenard M Lichtenberger
Melisa Barron
Upendra Marathi
P304
P356
10.1358/DOT.2009.45.12.1441075
P577
2009-12-01T00:00:00Z